Overview
- Under Development, FDA Approval Required.
- In Spring 2020, FLOVID-20 non-human primate studies were performed at the United States National Laboratory, University of Texas Medical Branch, Galveston
- Treated primates resisted infection. Control primates developed COVID pneumonia.
Current Status
-
PRE-CLINICAL FEASIBILITY
-
MANUFACTURING FOR CLINICAL TESTING
-
PHASE I/II CLINICAL TESTING
